MKI67 and neuroendocrine carcinoma: Notably, G3 patients demonstrated a significantly different Ki-67 distribution pattern compared to NEC (p<0.001), with the majority of G3 cases (18/25, 72%) showing Ki-67 indices below 55%, while most NEC cases (14/16, 87.5%) exhibited Ki-67 indices above 55%.